Analyst Ratings for Cytokinetics (CYTK)
CYTK Rating Summary
CYTK Price Target Summary
- Highest: $146.00 (B.Riley)
- Lowest: $80.00 (Evercore ISI)
- Average: $104.05
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$104.05 (+29.8%)
* Over Last 12-Mos
Rating Score: 9.2 / 10
Percentile Rank: 90%
Avg. $ Target:
$104.05 (+29.8%)
* Over Last 12-Mos
Rating Score: 9.2 / 10
Percentile Rank: 90%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/29/2026 | UBS | Ashwani Verma | Upgrade | Buy (Neutral) |
115.00 (69.00) |
80.80 (80.18) |
-0.77% | Details |
| 5/18/2026 | Citi | Eric Joseph | New Coverage | Buy (N/A) |
99.00 (N/A) |
75.85 (80.18) |
5.71% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
